273 related articles for article (PubMed ID: 20869467)
1. Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009.
Souayah N; Michas-Martin PA; Nasar A; Krivitskaya N; Yacoub HA; Khan H; Qureshi AI
Vaccine; 2011 Jan; 29(5):886-9. PubMed ID: 20869467
[TBL] [Abstract][Full Text] [Related]
2. Comment on the contribution by Souayah et al., "Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009".
Slade BA; Gee J; Broder KR; Vellozzi C
Vaccine; 2011 Jan; 29(5):865-6. PubMed ID: 21111783
[No Abstract] [Full Text] [Related]
3. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
Souayah N; Nasar A; Suri MF; Qureshi AI
J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.
Souayah N; Nasar A; Suri MF; Qureshi AI
Vaccine; 2007 Jul; 25(29):5253-5. PubMed ID: 17560693
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).
Souayah N; Yacoub HA; Khan HM; Farhad K; Mehyar LS; Maybodi L; Menkes DL; Qureshi AI
J Clin Neuromuscul Dis; 2012 Dec; 14(2):66-71. PubMed ID: 23172385
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
[TBL] [Abstract][Full Text] [Related]
8. Analysis of data from the CDC/FDA vaccine adverse event reporting system (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA.
Souayah N; Yacoub HA; Khan HM; Farhad K; Maybodi L; Qureshi AI; Menkes DL
J Clin Neurosci; 2012 Aug; 19(8):1089-92. PubMed ID: 22705140
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States.
Ojha RP; Jackson BE; Tota JE; Offutt-Powell TN; Singh KP; Bae S
Hum Vaccin Immunother; 2014; 10(1):232-7. PubMed ID: 24013368
[TBL] [Abstract][Full Text] [Related]
10. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Apr; 55(13):364-6. PubMed ID: 16601664
[TBL] [Abstract][Full Text] [Related]
11. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(41):1120-4. PubMed ID: 17060898
[TBL] [Abstract][Full Text] [Related]
12. Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004.
Haber P; Slade B; Iskander J
Vaccine; 2007 Nov; 25(48):8101. PubMed ID: 17933441
[No Abstract] [Full Text] [Related]
13. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
Lasky T; Terracciano GJ; Magder L; Koski CL; Ballesteros M; Nash D; Clark S; Haber P; Stolley PD; Schonberger LB; Chen RT
N Engl J Med; 1998 Dec; 339(25):1797-802. PubMed ID: 9854114
[TBL] [Abstract][Full Text] [Related]
14. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
15. A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.
Velentgas P; Bohn RL; Brown JS; Chan KA; Gladowski P; Holick CN; Kramer JM; Nakasato C; Spettell CM; Walker AM; Zhang F; Platt R
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1226-34. PubMed ID: 18956428
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.
Gold MS; McIntyre P
Sex Health; 2010 Sep; 7(3):320-4. PubMed ID: 20719221
[TBL] [Abstract][Full Text] [Related]
17. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
Vellozzi C; Burwen DR; Dobardzic A; Ball R; Walton K; Haber P
Vaccine; 2009 Mar; 27(15):2114-20. PubMed ID: 19356614
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome following influenza vaccination.
Haber P; DeStefano F; Angulo FJ; Iskander J; Shadomy SV; Weintraub E; Chen RT
JAMA; 2004 Nov; 292(20):2478-81. PubMed ID: 15562126
[TBL] [Abstract][Full Text] [Related]
19. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
[TBL] [Abstract][Full Text] [Related]
20. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
